Literature DB >> 8063600

Surgical treatment of thymoma in cats: 12 cases (1987-1992).

B R Gores1, J Berg, J L Carpenter, M G Aronsohn.   

Abstract

Twelve cats with thymoma were treated by surgical excision of the tumor alone. None of the cats received radiotherapy or chemotherapy. Two cats died or were euthanatized during the immediate postoperative period: 1 because of postsurgical hemorrhage, and the other because of an associated fungal pleuritis. None of the remaining 10 cats developed evidence of local tumor recurrence or metastases. Six of the cats were alive after follow-up periods ranging from 6 to 36 months (mean, 21 months; median, 21 months). Three cats were euthanatized 18 months, 32 months, and 45 months following surgery for unrelated problems, and 1 cat died as a result of trauma sustained 62 months postoperatively. Myasthenia gravis developed postoperatively in 2 of the cats.

Entities:  

Mesh:

Year:  1994        PMID: 8063600

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Thymoma-associated exfoliative dermatitis with post-thymectomy myasthenia gravis in a cat.

Authors:  Ameet Singh; Sarah E Boston; Roberto Poma
Journal:  Can Vet J       Date:  2010-07       Impact factor: 1.008

2.  Ultrasound guided electrochemotherapy for the treatment of a clear cell thymoma in a cat.

Authors:  Enrico Pierluigi Spugnini; Francesco Menicagli; Michela Pettorali; Alfonso Baldi
Journal:  Open Vet J       Date:  2017-03-08

3.  Temporal deterioration of neurological symptoms and increase of serum acetylcholine receptor antibody levels after thymectomy: a case report of a cat with myasthenia gravis.

Authors:  Nao Nagata; Takuma Miyoshi; Yuzo Otake; Hitomi Suzuki; Yumiko Kagawa; Tetsushi Yamagami; Mitsuhiro Irie
Journal:  J Vet Med Sci       Date:  2016-09-03       Impact factor: 1.267

4.  Risk Factors and Outcomes in Cats with Acquired Myasthenia Gravis (2001-2012).

Authors:  D W Hague; H D Humphries; M A Mitchell; G D Shelton
Journal:  J Vet Intern Med       Date:  2015-08-26       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.